Bodycote PLC (LON:BOY)‘s stock had its “buy” rating reaffirmed by stock analysts at Deutsche Bank AG in a research report issued on Monday. They presently have a GBX 685 ($8.56) price target on the stock. Deutsche Bank AG’s price target points to a potential upside of 18.00% from the company’s current price.
BOY has been the subject of several other research reports. Canaccord Genuity reaffirmed a “buy” rating and set a GBX 680 ($8.50) price objective on shares of Bodycote PLC in a research note on Wednesday, October 12th. JPMorgan Chase & Co. raised shares of Bodycote PLC to a “neutral” rating and boosted their price objective for the company from GBX 565 ($7.06) to GBX 605 ($7.56) in a research note on Monday, August 22nd. Royal Bank Of Canada boosted their price objective on shares of Bodycote PLC from GBX 550 ($6.87) to GBX 590 ($7.37) and gave the company a “sector performer” rating in a research note on Monday, August 1st. Credit Suisse Group AG reaffirmed an “outperform” rating on shares of Bodycote PLC in a research note on Monday, October 3rd. Finally, N+1 Singer boosted their price objective on shares of Bodycote PLC from GBX 635 ($7.93) to GBX 690 ($8.62) and gave the company a “buy” rating in a research note on Wednesday, October 12th. Four research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. The company currently has an average rating of “Buy” and an average price target of GBX 660.57 ($8.25).
Shares of Bodycote PLC (LON:BOY) remained flat at GBX 580.50 during trading on Monday. 214,346 shares of the company were exchanged. The company’s 50-day moving average is GBX 597.92 and its 200-day moving average is GBX 589.58. Bodycote PLC has a 52 week low of GBX 493.30 and a 52 week high of GBX 644.50. The company’s market capitalization is GBX 1.10 billion.